Catalyst Biosciences (NASDAQ:CBIO) Stock Attempts To Bounce Back: Time to Buy?
Catalyst Biosciences (NASDAQ:CBIO) gained 5% after presenting its first poster during the 2021 International Society for Thrombosis and Haemostasis virtual
Read more
NASDAQ:CBIO